How a ‘pain-o-meter’ could improve treatments
Elie Dolgin • September 25, 2024
Pain is defined subjectively, but an objective measure of the experience promises to transform its management.
Read at Nature Outlook.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.